2 documents found, page 1 of 1

Sort by Issue Date

Corrigendum to "A New Technical Approach for Cross-species Examination of Neuro...

Edwards-Faret, G; Vin, F; Slezak, M; Gollenbeck, L; Karaman, R; Shinmyo, Y; Batiuk, MY; Pando, CM; Urschitz, J; Rincon, MY; Moisyadi, S; Schnütgen, F


AAV-mediated delivery of an anti-BACE1 VHH alleviates pathology in an Alzheimer...

Marino, M; Zhou, L; Rincon, MY; Callaerts-Vegh, Z; Verhaert, J; Wahis, J; Creemers, E; Yshii, L; Wierda, K; Saito, T; Marneffe, C; Voytyuk, I

Single domain antibodies (VHHs) are potentially disruptive therapeutics, with important biological value for treatment of several diseases, including neurological disorders. However, VHHs have not been widely used in the central nervous system (CNS), largely because of their restricted blood-brain barrier (BBB) penetration. Here, we propose a gene transfer strategy based on BBB-crossing adeno-associated virus (...


2 Results

Queried text

Refine Results

Author





















Date



Document Type


Access rights


Resource


Subject